BAYER HLTHCARE FDA Approval NDA 021225

NDA 021225

BAYER HLTHCARE

FDA Drug Application

Application #021225

Documents

Letter2008-05-30
Letter2008-06-06
Letter2008-07-24
Letter2009-11-10
Letter2015-10-26
Letter2013-08-08
Review2004-05-06
Review2016-02-03
Letter2004-01-14
Letter2003-08-29
Label2008-07-22
Label2009-10-14
Label2015-10-26
Label2013-08-09
Label2014-05-30
Review2015-03-09
Label2016-12-21
Letter2016-12-23
Label2017-05-30
Letter2017-05-30
Label2017-06-08
Letter2017-06-09
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Label2020-08-21
Letter2020-08-21
Letter2021-05-27
Letter2021-06-09
Label2021-06-10
Label2021-08-12
Letter2021-08-12
Letter2022-08-15
Label2022-08-15

Application Sponsors

NDA 021225BAYER HLTHCARE

Marketing Status

Prescription001

Application Products

001INTRAUTERINE DEVICE;INTRAUTERINE52MG1MIRENALEVONORGESTREL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2000-12-06STANDARD
LABELING; LabelingSUPPL2AP2001-10-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2001-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2002-03-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2002-03-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2002-11-27STANDARD
LABELING; LabelingSUPPL9AP2004-01-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2003-08-27STANDARD
LABELING; LabelingSUPPL17AP2008-05-28STANDARD
LABELING; LabelingSUPPL18AP2008-06-02STANDARD
LABELING; LabelingSUPPL19AP2008-07-21STANDARD
EFFICACY; EfficacySUPPL27AP2009-10-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2014-03-07STANDARD
LABELING; LabelingSUPPL31AP2015-10-22STANDARD
LABELING; LabelingSUPPL32AP2013-08-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2014-05-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2014-05-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2014-12-08STANDARD
LABELING; LabelingSUPPL36AP2021-06-08STANDARD
LABELING; LabelingSUPPL37AP2016-12-21STANDARD
EFFICACY; EfficacySUPPL38AP2017-06-08STANDARD
LABELING; LabelingSUPPL39AP2017-05-25STANDARD
EFFICACY; EfficacySUPPL40AP2020-08-20STANDARD
LABELING; LabelingSUPPL41AP2021-05-26STANDARD
EFFICACY; EfficacySUPPL42AP2021-08-11STANDARD
EFFICACY; EfficacySUPPL43AP2022-08-12STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL10Null0
SUPPL27Null6
SUPPL29Null0
SUPPL31Null15
SUPPL32Null6
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null15
SUPPL37Null7
SUPPL38Null7
SUPPL39Null15
SUPPL40Null6
SUPPL41Null6
SUPPL42Null6
SUPPL43Null6

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21225
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.